Obalon Announces Third Quarter 2017 Financial Results
03 nov. 2017 07h29 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 03, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. and Sono Bello Announce Agreement to Offer Novel Weight Loss Treatment in Sono Bello Centers
02 nov. 2017 16h06 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) and Sono Bello announced today that they had reached an agreement to begin offering the novel Obalon Balloon...
Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time
26 oct. 2017 08h01 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
Kelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive Team
07 sept. 2017 08h58 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Kelly Huang, Ph.D., has joined as its...
Obalon Announces Second Quarter 2017 Financial Results
02 août 2017 07h59 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
31 juil. 2017 08h45 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Second Quarter 2017 Financial Results Conference Call for August 2, 2017 at 8:30 a.m. Eastern Time
27 juil. 2017 07h50 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 27, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. to Present at UBS Global Healthcare Conference
22 mai 2017 09h05 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
11 mai 2017 08h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
11 mai 2017 08h02 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...